Pharmascience is teaming up with BioQuébec

Pharmascience is proud to join BioQuébec, to promote and enhance the growth and autonomy of Quebec’s biotechnology, biomanufacturing and life sciences industry.

Pharmascience, whose head office and all its facilities are located in the Greater Montréal region, values the life sciences continuum in Quebec, from support for academic research, to development and manufacturing all the way through to marketing.

The Pharmascience group offers a wide range of services in the healthcare sector. It has business units specializing in bioanalytical analyses of large and small molecules for toxicokinetics and pharmacokinetics (Royalmount Laboratories), in the co-development and marketing of pharmaceutical products, as well as the development and contract manufacturing of pharmaceutical products (Pharmascience). It also has a venture capital subsidiary (Finchley Healthcare Ventures).

Furthermore, our production facilities, approved by Health Canada, the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), enable the manufacture of solid dosage forms, complex formulations and injectable, suspension and lyophilized products.

“Pharmascience is proud to be associated with BioQuébec and to add its voice to those of its members, in support of their critical work.  It is crucial to promote the added value of our industry and our Quebec know-how in the vital life sciences sector.” Martin Arès, CEO, Pharmascience.



Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec. With 1,500 employees proudly headquartered in Montreal, Pharmascience Inc. is a full-service, privately-owned pharmaceutical company with strong roots in Canada and a growing global reach, with product distribution in over 50 countries. Ranked 50th among Canada’s top 100 Research and Development (R&D) investors in 2022, with $40-50 million in annual investment, Pharmascience Inc. is among the largest drug manufacturers in Canada.

Pharmascience Inc. has strong values based on the importance of investing in its employees and young people. Through various programs and initiatives, the company ensures it supports their personal development and life. In 2023, Pharmascience Inc. has proudly been recognized for its investments by being selected as one of Canada’s Top Employers for Young People as part of Canada’s Top 100 Employers. Also as of 2023, Pharmascience is now certified as a Great Place to Work for its second year in a row.

Published in

Business News